ARTICLE | Company News
Sarepta Therapeutics, U.S. Department of Defense infectious news
September 10, 2012 7:00 AM UTC
Sarepta received a $3.9 million contract from DoD's Joint Project Manager Transformational Medical Technologies (JPM-TMT) program to evaluate the feasibility of intramuscular formulation of AVI-7288 ...